Kondo Takeshi 近藤健

… Alternative Names

近藤健コンドウタケシ

KONDO TAKESHI 近藤健

Less

Researcher Number	70333606
Other IDs
External Links
Affiliation (Current)	2025: 北海道大学, 医学研究院, 客員研究員
Affiliation (based on the past Project Information) *help	2020 – 2023: 北海道大学, 医学研究院, 客員研究員 2013 – 2015: 北海道大学, 医学(系)研究科(研究院), 講師 2004: 北海道大学, 病院, 助手 2003: 北海道大学, 医学部・歯学部附属病院, 助手
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related / Hematology
Keywords	Principal Investigator チロシンキナーゼ阻害剤 / 薬剤感受性 / FRET / BCR-ABL1 / エピゲノム関連遺伝子 / BCR::ABL1 / 慢性骨髄性白血病 / Drug Resistance / Leukemia / leukemia … More / SUMO化 / Ph+ALL / TKI / BCR-ABL / アポトーシス / DNA損傷 / ユビキチン / Cdt1 / チェックポイント Less

慢性骨髄性白血病におけるDMR達成率向上の治療戦略の開発Principal Investigator
- Principal Investigator
  
  近藤健
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Hokkaido University
慢性骨髄性白血病におけるDMR達成率向上の治療戦略の開発Principal Investigator
- Principal Investigator
  
  近藤健
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Hokkaido University
Analyzing the mechanism of TKI-resistance in Ph-positive ALLPrincipal Investigator
- Principal Investigator
  
  KONDO TAKESHI
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Hokkaido University
造血器悪性腫瘍の抗癌剤、放射線治療抵抗性の分子機構解析と分子標的療法の開発Principal Investigator
- Principal Investigator
  
  近藤健
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hematology
- Research Institution
  Hokkaido University

All 2016 2015 2014 2004 Other

All Journal Article Presentation

[Journal Article] Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia.2016
- Author(s)
  Ishida Y, Murai K, Yamaguchi K, Miyagishima T, Shindo M, Ogawa K, Nagashima T, Sato S, Watanabe R, Yamamoto S, Hirose T, Saitou S, Yonezumi M, Kondo T, Kato Y, Mochizuki N, Ohno K, Kishino S, Kubo K, Oyake T, Ito S; Inter-Michinoku Dasatinib Study Group (IMIDAS)
- Journal Title
  
  Eur J Clin Pharmacol.
  
  Volume: 72 Issue: 2 Pages: 185-193
- DOI
  10.1007/s00228-015-1968-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25461404, KAKENHI-PROJECT-25461458
[Journal Article] Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.2015
- Author(s)
  Shiratori S, Kosugi-Kanaya M, Shigematsu A, Kobayashi H, Yamamoto S, Kobayashi N, Iwasaki H, Mori A, Kunieda Y, Yutaka T, Kurosawa M, Kakinoki Y, Endo T, Kondo T, Hashino S, Teshima T
- Journal Title
  
  Leukemia & Lymphoma
  
  Volume: - Issue: 9 Pages: 2592-2597
- DOI
  10.3109/10428194.2014.1001985
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25860775, KAKENHI-PROJECT-25461404
[Journal Article] Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.2015
- Author(s)
  Shibayama Y, Kondo T, Ohya H, Fujisawa S, Teshima T, Iseki K.
- Journal Title
  
  Oncol Rep.
  
  Volume: 33 Issue: 5 Pages: 2176-2182
- DOI
  10.3892/or.2015.3839
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25461404
[Journal Article] FIP1L1 presence in FIP1L1-RARA or FIP1L1-PDGFRA differentially contributes to the pathogenesis of distinct types of leukemia2014
- Author(s)
  Junko Iwasaki, Takeshi Kondo, Stephanie Darmanin, Makoto Ibata, Masahiro Onozawa, Daigo Hashimoto, Naoya Sakamoto and Takanori Teshima
- Journal Title
  
  Annals of Hematology
  
  Volume: 未定 Issue: 9 Pages: 1473-1482
- DOI
  10.1007/s00277-014-2085-1
- NAID
  120005656326
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25461404, KAKENHI-PROJECT-26461438
[Journal Article] Rapid degradation of Cdt1 upon UV-induced DNA damage is mediated by SCF^<Skp2> complex2004
- Author(s)
  Kondo T. et al.
- Journal Title
  
  Journal of Biological Chemistry 279(26)
  
  Pages: 27315-27319
- Data Source
  KAKENHI-PROJECT-15790485
[Presentation] 成人CMLにおける移植前チロシンキナーゼ阻害剤使用と移植成績の解析～TKI時代での検討2016
- Author(s)
  近藤　健、大橋一輝、長村登紀子、東條有伸、内田直之、中前博久、矢野真吾、福田隆浩、橋本尚子、鬼塚真仁、高梨美乃子、一戸辰夫、熱田由子、豊嶋崇徳
- Organizer
  第３８回日本造血細胞移植学会総会
- Place of Presentation
  名古屋国際会議場（愛知県・名古屋市）
- Year and Date
  2016-03-03
- Data Source
  KAKENHI-PROJECT-25461404
[Presentation] IDENTIFICATION OF FIP1L1-PDGFRA ASSOCIATING MOLECULE THAT LOCATES IN THE NUCLEUS AND AUGMENTS THE ACTIVITY OF FIPAL1-PDGFRA.2015
- Author(s)
  Takeshi Kondo, Makoto Ibata, Junko Iwasaki, Yoichiro Fujioka, Koji Nakagawa, Stephanie Darmanin, Masahiro Onozawa, Daigo Hashimoto, Yusuke Ohba, Shigetsugu Hatakeyama, Takanori Teshima
- Organizer
  European Association of Hematology 20th Congress
- Place of Presentation
  Vienna (Austria)
- Year and Date
  2015-06-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25461404
[Presentation] FRET-based drug sensitivity test predicts clinical response of nilotinib in CML-CP patients.
- Author(s)
  Kondo T, Ohba Y, Fujisawa S, Miyagishima T, Mori A, Iwasaki H, Shindo M, Kakinoki Y, Kobayashi N, Yamamoto S, Haseyama Y, Ando S, Kohgo Y, Teshima T
- Organizer
  第７６回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場（大阪府・大阪市）
- Year and Date
  2014-10-31 – 2014-11-02
- Data Source
  KAKENHI-PROJECT-25461404
[Presentation] Impact of Genetic Alterlations and MRD Reduction on the Outcome of Intermediate-Risk Acute Myelogenous Leukemia.
- Author(s)
  Kondo T, Fujisawa S, Sato A, Mori A, Imai K, Yamamoto S, Kakinoki Y, Miyagishima T, Tsutsumi Y, Haseyama Y, Wada Y, Kurosawa M, Iwasaki H, Imamura M, Teshima T
- Organizer
  5th JSH International Symposium
- Place of Presentation
  アクトシティ浜松コングレスセンター（静岡県・浜松市）
- Year and Date
  2014-05-24 – 2014-05-25
- Data Source
  KAKENHI-PROJECT-25461404
[Presentation] MULTICENTER CLINICAL STUDY TO EVALUATE A UTILITY OF FRET-BASED DRUG SENRITIVITY TEST THAT PREDICTS EARLY MOLECULAR RESPONSE IN NEWLY DIAGNOSED CML PATIENTS TREATED WITH NILOTINIB
- Author(s)
  Kondo T, Ohba Y, Miyagishima T, Mori A, Iwasaki H, Shindo M, Kakinoki Y, Kobayashi N, Yamamoto S, Haseyama Y, Ando S, Fujimoto N, Nishio M, Kurosawa M, Kohgo Y, Teshima T
- Organizer
  European Association of Hematology 19th Congress
- Place of Presentation
  Milan ( Italy )
- Year and Date
  2014-06-12 – 2014-06-15
- Data Source
  KAKENHI-PROJECT-25461404

1. OHBA Yusuke (30333503)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
2. MINAMI YOSUKE (60513752)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 小野澤真弘 (70455632)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 白鳥聡一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kondo Takeshi 近藤 健

近藤 健 コンドウ タケシ

KONDO TAKESHI 近藤 健

Research Projects

Research Products

Co-Researchers

慢性骨髄性白血病におけるDMR達成率向上の治療戦略の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

慢性骨髄性白血病におけるDMR達成率向上の治療戦略の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analyzing the mechanism of TKI-resistance in Ph-positive ALLPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

造血器悪性腫瘍の抗癌剤、放射線治療抵抗性の分子機構解析と分子標的療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] FIP1L1 presence in FIP1L1-RARA or FIP1L1-PDGFRA differentially contributes to the pathogenesis of distinct types of leukemia2014

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Rapid degradation of Cdt1 upon UV-induced DNA damage is mediated by SCF^<Skp2> complex2004

Author(s)

Journal Title

Data Source

[Presentation] 成人CMLにおける移植前チロシンキナーゼ阻害剤使用と移植成績の解析～TKI時代での検討2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] IDENTIFICATION OF FIP1L1-PDGFRA ASSOCIATING MOLECULE THAT LOCATES IN THE NUCLEUS AND AUGMENTS THE ACTIVITY OF FIPAL1-PDGFRA.2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] FRET-based drug sensitivity test predicts clinical response of nilotinib in CML-CP patients.

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Impact of Genetic Alterlations and MRD Reduction on the Outcome of Intermediate-Risk Acute Myelogenous Leukemia.

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] MULTICENTER CLINICAL STUDY TO EVALUATE A UTILITY OF FRET-BASED DRUG SENRITIVITY TEST THAT PREDICTS EARLY MOLECULAR RESPONSE IN NEWLY DIAGNOSED CML PATIENTS TREATED WITH NILOTINIB

Kondo Takeshi 近藤健

近藤健コンドウタケシ

KONDO TAKESHI 近藤健